Abstract
Aim: Soluble (s) ST2, a member of the interleukin-1 family, has been suggested to play a role in cardiac remodelling and inflammatory signalling. We assessed the long-term predictive value of sST2 in stable coronary heart disease (CHD) patients, simultaneously controlling for a large number of potential confounders.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
